This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: The Innovative Contributions of Anthony Winiski
Introduction
Anthony Winiski is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of medicinal chemistry, particularly in the development of therapeutic agents. With a focus on CCR9 inhibitors, his work has implications for treating various diseases.
Latest Patents
Winiski holds 2 patents that showcase his innovative approach. His latest patents include "N-arylsulfonyl-2,3-dihydro-1H-indoles and the use thereof as CCR9 inhibitors" and "N-(benzenesulphonyl)-2,3-dihydro-1H-indols, wherein the indol is substituted by cyano, carboxy or alkylcarbonyloxy and their use as therapeutical agents." These patents detail compounds that inhibit CCR9 activity, which are useful for therapeutic treatment.
Career Highlights
Winiski is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to further his research and development efforts in the pharmaceutical industry. His contributions have been instrumental in advancing the understanding of CCR9 inhibitors.
Collaborations
Throughout his career, Winiski has collaborated with esteemed colleagues, including Jose M Carballido Herrera and Herbert Jaksche. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Anthony Winiski's innovative work in the field of medicinal chemistry, particularly with CCR9 inhibitors, highlights his significant contributions to therapeutic advancements. His patents and collaborations reflect a commitment to improving healthcare through scientific innovation.